HT
REGN icon

Heritage Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Heritage Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Buy
2,656
+77
+3% +$59K 0.21% 115
2025
Q4 		$1.99M Buy
2,579
+50
+2% +$34K 0.2% 114
2025
Q3 		$1.42M Buy
2,529
+160
+7% +$90.5K 0.15% 140
2025
Q2 		$1.24M Buy
2,369
+185
+8% +$103K 0.14% 145
2025
Q1 		$1.39M Sell
2,184
-227
-9% -$156K 0.17% 131
2024
Q4 		$1.72M Buy
+2,411
New +$2.02M 0.2% 115
2024
Q2 		$2.41M Buy
2,291
+26
+1% +$25.2K 0.32% 87
2024
Q1 		$2.18M Buy
2,265
+19
+0.8% +$18.1K 0.29% 92
2023
Q4 		$1.97M Buy
2,246
+118
+6% +$97.2K 0.28% 92
2023
Q3 		$1.75M Buy
2,128
+42
+2% +$33K 0.27% 93
2023
Q2 		$1.5M Buy
2,086
+2
+0.1% +$1.54K 0.22% 104
2023
Q1 		$1.71M Buy
2,084
+59
+3% +$44.5K 0.27% 98
2022
Q4 		$1.46M Buy
2,025
+98
+5% +$72.3K 0.24% 105
2022
Q3 		$1.33M Sell
1,927
-739
-28% -$465K 0.23% 106
2022
Q2 		$1.58M Sell
2,666
-41
-2% -$26.7K 0.26% 98
2022
Q1 		$1.89M Buy
2,707
+166
+7% +$105K 0.27% 97
2021
Q4 		$1.6M Buy
2,541
+1,020
+67% +$627K 0.21% 110
2021
Q3 		$920K Buy
1,521
+340
+29% +$211K 0.13% 136
2021
Q2 		$660K Sell
1,181
-214
-15% -$108K 0.09% 160
2021
Q1 		$660K Buy
1,395
+132
+10% +$64.3K 0.1% 153
2020
Q4 		$610K Buy
1,263
+25
+2% +$13.5K 0.1% 151
2020
Q3 		$693K Buy
1,238
+102
+9% +$61.8K 0.13% 129
2020
Q2 		$708K Buy
+1,136
New +$645K 0.14% 128
2019
Q1 		– Sell
-26
Closed -$10K – 360
2018
Q4 		$10K Hold
26
– – ﹤0.01% 313
2018
Q3 		$11K Hold
26
– – ﹤0.01% 313
2018
Q2 		$9K Buy
+26
New +$8.13K ﹤0.01% 315

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Heritage Trust's REGN Position: Q1 2026 in Review

Heritage Trust increased its Regeneron Pharmaceuticals (REGN) stake by 3% in Q1 2026, buying an estimated $59K and bringing the position to 2,656 shares worth $2.05M. The position accounts for 0.21% of the portfolio, ranked #115.

Heritage Trust first reported a position in REGN in Q2 2018 and has held it in 26 quarters since. The position peaked at $2.41M in Q2 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Heritage Trust held 2,656 shares of Regeneron Pharmaceuticals worth $2.05M as of Q1 2026.
  • Heritage Trust bought 77 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $59K.
  • Regeneron Pharmaceuticals made up 0.21% of Heritage Trust's portfolio in Q1 2026, its #115 holding.
  • Heritage Trust first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 26 quarters since.
  • Heritage Trust's Regeneron Pharmaceuticals position peaked at $2.41M in Q2 2024.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Heritage Trust's 13F filing for Q1 2026, filed 13 May 2026.